Mariani Justin A, Weerasooriya Rukshen, van den Brink Olivier, Mohamed Uwais, Gould Paul A, Pathak Rajeev K, Lin Tina, Conradie Andre, Illes Peter, Pavia Stephen, Rajamani Kushwin, Lovibond Sam, Matthews Ian, DiFiore David, Arumugam Deepak, Schrader Jürgen, Lau Dennis H
The Alfred Hospital, 55 Commercial Rd, Melbourne, VIC 3004, Australia; Central Clinical School, Monash University, 99 Commercial Rd, Melbourne, VIC 3004, Australia.
University of Western Australia, Department of Medicine, Crawley, WA 6000, Australia.
J Electrocardiol. 2020 May-Jun;60:118-125. doi: 10.1016/j.jelectrocard.2020.04.004. Epub 2020 Apr 11.
Implantable Cardiac Monitors (ICMs) are used for long-term monitoring of arrhythmias. BIOMONITOR III is a novel ICM with a miniaturized profile, long sensing vector due to a flexible antenna, simplified implantation with a dedicated insertion tool for pocket formation and ICM placement in a single step, and daily automatic Home Monitoring (HM) function.
In 47 patients undergoing BIOMONITOR III insertion for any ICM indication, 16 investigators at 10 Australian sites assessed handling characteristics of the insertion tool, R-wave amplitudes, noise burden, P-wave visibility, and HM transmission success. Patients were followed for 1 month.
All 47 attempted insertions were successful. Median time from skin incision to removal of the insertion tool after ICM insertion was 39 s (IQR 19-65) and to wound closure and cleaning was 4.7 min (IQR 3.5-7.8). All aspects of the insertion tool were rated as "good" or "excellent" in ≥97.9% and "fair" in ≤2.1% of patients, except for "force needed for tunnelling" (91.5% good/excellent, 8.5% fair). Based on HM data, R-waves in the first month were stable at 0.70 ± 0.37 mV. Median noise burden (disabling automatic rhythm evaluation) was 0.19% (IQR 0.00-0.93), equivalent to 2.7 min (IQR 0.0-13.4) per day. In HM-transmitted ECG strips with regular sinus rhythm, P-waves were visible in 89 ± 24% of heart cycles. Patient-individual automatic Home Monitoring transmission success was 98.0% ± 5.5%.
The novel ICM performed well in all aspects studied, including fast insertion, reliable R-wave sensing, good P-wave visibility, and highly successful HM transmissions.
植入式心脏监测器(ICM)用于心律失常的长期监测。BIOMONITOR III是一款新型ICM,外形小巧,因其柔性天线具有较长的传感向量,使用专门的插入工具进行囊袋形成和ICM放置,一步完成简化植入,且具备每日自动家庭监测(HM)功能。
在47例因任何ICM适应证而接受BIOMONITOR III植入的患者中,澳大利亚10个地点的16名研究人员评估了插入工具的操作特性、R波振幅、噪声负荷、P波可见性和HM传输成功率。对患者进行了1个月的随访。
47例植入尝试均成功。ICM植入后从皮肤切开到取出插入工具的中位时间为39秒(四分位间距19 - 65),到伤口闭合和清洁的时间为4.7分钟(四分位间距3.5 - 7.8)。除“隧道挖掘所需力量”外,插入工具的所有方面在≥97.9%的患者中被评为“良好”或“优秀”,在≤2.1%的患者中被评为“一般”(“隧道挖掘所需力量”:91.5%良好/优秀,8.5%一般)。根据HM数据,第一个月的R波稳定在0.70±0.37mV。中位噪声负荷(使自动心律评估无效)为0.19%(四分位间距0.00 - 0.93),相当于每天2.7分钟(四分位间距0.0 - 13.4)。在具有正常窦性心律的HM传输心电图条中,89±24%的心搏周期可见P波。患者个体自动家庭监测传输成功率为98.0%±5.5%。
这款新型ICM在所有研究方面表现良好,包括快速植入、可靠的R波传感、良好的P波可见性和高度成功的HM传输。